Tests for Gastroesophageal reflux disease (Gerd) including Barrett's esophagus

  1. ๐Ÿ“š Citations
  2. ๐Ÿฆ  Taxons (Bacteria) report by studies
  3. ๐Ÿฅฃ Candidates for improving (avoids and takes)
  4. ๐Ÿ”ฎ Bacteria Related Conditions
  5. es-xenogene is located in Spain and is expensive compared to others

Some 16s providers support download of FASTQ (raw data - BIG FILES). These can be processed thru other services (at the moment, Thryve and Biomesight offers free processing). The bacteria is determine by computer algorithms, which differs from lab to lab.

  1. Biomesight and BiomeSightRdp ships worldwide - including the US
  2. Thryve is now Ombre Labs but only ships to the US
  3. CosmosId is available thru NirvanaBiome
  4. Medivere is based in Germany
  5. American Gut
  6. Xenogene is both the most expensive and most detail for rare bacteria. They are based in Spain
  7. uBiome is no longer in business
The Percentage of significant bacteria each test reports on
Name Percentage
es-xenogene 97%
uBiome 97%
FASTQ processed thru both Thryve and BiomeSight 97%
Thorne 93.9%
Thryve 93.9%
CerbaLab 90.9%
BiomeSight 84.8%
BiomeSightRdp 78.8%
CosmosId 78.8%
Medivere 75.8%
Microba 72.7%
SequentiaBiotech 72.7%
bugspeak 72.7%
Tiny 57.6%
Laboratorio Teletest 51.5%
Gut Zoomer (vibrant-wellness) 42.4%
AmericanGut 39.4%
Diagnostic Solution GI-Map (cfu/gm) 33.3%
Genova Gi Effects (cfu/g) 33.3%
GanzimmunDiag 30.3%
Microba1 27.3%
Microbiome Healthpath Maxi 27.3%
GanzImmun Diagnostic A6 (cfu/gm) 24.2%
Biovis Microbiome Plus (cfu/g) 24.2%
GI360 Stool (UK) 24.2%
DayTwo 21.2%
Nordic Laboratories 21.2%
Medivere Mikrobiom Plus Stuhlanalyse 21.2%
Tarmkollen Mega 18.2%
Viome (Latest Reports Fail to provide ANY measurements) 18.2%
Smart Gut (ubiome 16s - Limited Taxonomy) 15.2%
NutriPATH 12.1%
GanzImmun Diagnostics AG Befundbericht 12.1%
Bioscreen (cfu/gm) 12.1%
GI EcologiX (Invivo) 12.1%
Medivere: Darm Mikrobiom Stuhltest (16s limited) 9.1%
Metagenomics Stool (De Meirleir) (16s Limited) 9.1%
InVitaLab (cfu/gm) 3%
Genova Parasitology (cfu/g) 3%

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.

Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 ยงโ€ฏ1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.